Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension.

The Journal of rheumatology - 1 Aug 2008

Johnson Sindhu R, Swiston John R, Swinton John R, Granton John T

Abstract excerpt

OBJECTIVE: Identification of prognostic factors for survival in systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) is necessary for appropriate monitoring, interventions, and timely referral for lung transplantation. Our objectives were (1) to identify factors associated with survival in SSc-PAH and (2) to evaluate the methodologic quality of prognostic studies against current standards....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to HLA-DR Antigens
Share to HLA-DR Serological Subtypes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertension, Pulmonary

Share to Pulmonary Artery

Share to Scleroderma, Systemic

Share to Sex Factors

Share to Survival Analysis

Source

Identifiers

PMID: 18597400

Genes

PAH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic factors for survival in scleroderma associated pulmonary arterial hypertension.PMID 18597400Read ↗

Pulmonary Hypertension: How to Best Treat the Different Scleroderma Phenotypes?Semantic proximity Read ↗

Pulmonary hypertension phenotypes in patients with systemic sclerosis.Semantic proximity Read ↗

Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment.Semantic proximity Read ↗

Proteomic Biomarkers for Survival in Systemic Sclerosis-associated Pulmonary HypertensionSemantic proximity Read ↗

Cardiopulmonary phenotype in systemic sclerosis associated pulmonary hypertension.Semantic proximity Read ↗

Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.Semantic proximity Read ↗

Treatable Traits in Systemic Sclerosis.Semantic proximity Read ↗

Mortality in systemic sclerosis-a single centre study from the UK.Semantic proximity Read ↗

Pulmonary hypertension in systemic sclerosis: different phenotypes.Semantic proximity Read ↗

Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.Semantic proximity Read ↗

Clinical and genetic factors predictive of mortality in early systemic sclerosis.Semantic proximity Read ↗

Scleroderma Clinical Trials Consortium Classification Criteria for Systemic Sclerosis Heart InvolvementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.